ArticleTranslational andrology and urology2019
A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer.
Archana Agarwal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.